Tăng cường độ gắn kết của kháng thể tương tác chéo chống lại virus sốt xuất huyết thông qua hỗ trợ bằng máy tính

Monath, T. P. (1994). Dengue: the risk to developed and developing countries. Proceedings of the National Academy of Sciences, 91(7), 2395–2400. https://doi.org/10.1073/pnas.91.7.2395. Bhatt, S., Gething, P. W., Brady, O. J., Messina, J. P., Farlow, A. W., Moyes, C. L., & Hay, S. I. (2013). The global distribution and burden of dengue. Nature, 496(7446), 504–507. https://doi.org/10.1038/nature12060. Shepard, D. S., Undurraga, E. A., Halasa, Y. A., & Stanaway, J. D. (2016). The global economic burden of dengue: a systematic analysis. The Lancet Infectious Diseases, 16(8), 935–941. https://doi.org/10.1016/S1473-3099(16)00146-8. Mackenzie, J. S., Gubler, D. J., & Petersen, L. R. (2004). Emerging flaviviruses: the spread and resurgence of Japanese encephalitis, West Nile and dengue viruses. Nature Medicine, 10(S12), S98–S109. https://doi.org/10.1038/nm1144. Sabin, A. B. (1952). Research on Dengue during World War II 1. The American Journal of Tropical Medicine and Hygiene, 1(1), 30–50. https://doi.org/10.4269/ajtmh.1952.1.30. Sangkawibha, N., Rojanasuphot, S., Ahandrik, S., Viriyapongse, S., Jatanasen, S., Salitul, V., & Halstead, S. B. (1984). RISK FACTORS IN DENGUE SHOCK SYNDROME: A PROSPECTIVE EPIDEMIOLOGIC STUDY IN RAYONG, THAILAND. American Journal of Epidemiology, 120(5), 653–669. https://doi.org/10.1093/oxfordjournals.aje.a113932. Halstead, S., & O’Rourke, E. (1977). Dengue viruses and mononuclear phagocytes. I. Infection enhancement by non-neutralizing antibody. Journal of Experimental Medicine, 146(1), 201–217. https://doi.org/10.1084/jem.146.1.201. Capeding, M. R., Tran, N. H., Hadinegoro, S. R. S., Ismail, H. I. H. M., Chotpitayasunondh, T., Chua, M. N., & Bouckenooghe, A. (2014). Clinical efficacy and safety of a novel tetravalent dengue vaccine in healthy children in Asia: a phase 3, randomised, observer-masked, placebo-controlled trial. The Lancet, 384(9951), 1358–1365. https://doi.org/10.1016/S0140-6736(14)61060-6. Sabchareon, A., Wallace, D., Sirivichayakul, C., Limkittikul, K., Chanthavanich, P., Suvannadabba, S., & Lang, J. (2012). Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled phase 2b trial. The Lancet, 380(9853), 1559–1567. https://doi.org/10.1016/S0140-6736(12)61428-7. Villar, L., Dayan, G. H., Arredondo-García, J. L., Rivera, D. M., Cunha, R., Deseda, C., & Noriega, F. (2015). Efficacy of a Tetravalent Dengue Vaccine in Children in Latin America. New England Journal of Medicine, 372(2), 113–123. https://doi.org/10.1056/NEJMoa1411037. Perera, R., & Kuhn, R. J. (2008). Structural proteomics of dengue virus. Current Opinion in Microbiology, 11(4), 369–377. https://doi.org/10.1016/j.mib.2008.06.004. Crill, W. D., & Roehrig, J. T. (2001). Monoclonal Antibodies That Bind to Domain III of Dengue Virus E Glycoprotein Are the Most Efficient Blockers of Virus Adsorption to Vero Cells. Journal of Virology, 75(16), 7769–7773. https://doi.org/10.1128/JVI.75.16.7769-7773.2001. Caskey, M., Klein, F., Lorenzi, J. C. C., Seaman, M. S., West, A. P., Buckley, N., & Nussenzweig, M. C. (2015). Viraemia suppressed in HIV-1-infected humans by broadly neutralizing antibody 3BNC117. Nature, 522(7557), 487–491. https://doi.org/10.1038/nature14411. Ramos, E. L., Mitcham, J. L., Koller, T. D., Bonavia, A., Usner, D. W., Balaratnam, G., & Swiderek, K. M. (2015). Efficacy and Safety of Treatment With an Anti-M2e Monoclonal Antibody in Experimental Human Influenza. Journal of Infectious Diseases, 211(7), 1038–1044. https://doi.org/10.1093/infdis/jiu539. Siber, G. R., Werner, B. G., Halsey, N. A., Reid, R., Almeido-Hill, J., Garrett, S. C., & Santosham, M. (1993). Interference of immune globulin with measles and rubella immunization. The Journal of Pediatrics, 122(2), 204–211. https://doi.org/10.1016/S0022-3476(06)80114-9. Siegrist, C.-A., Córdova, M., Brandt, C., Barrios, C., Berney, M., Tougne, C., & Lambert, P.-H. (1998). Determinants of infant responses to vaccines in presence of maternal antibodies. Vaccine, 16(14–15), 1409–1414. https://doi.org/10.1016/S0264-410X(98)00100-5. Smith, S. A., de Alwis, A. R., Kose, N., Harris, E., Ibarra, K. D., Kahle, K. M., & Crowe, J. E. (2013). The Potent and Broadly Neutralizing Human Dengue Virus-Specific Monoclonal Antibody 1C19 Reveals a Unique Cross-Reactive Epitope on the bc Loop of Domain II of the Envelope Protein. mBio, 4(6), e00873–13. https://doi.org/10.1128/mBio.00873-13. Lai, C.-Y., Tsai, W.-Y., Lin, S.-R., Kao, C.-L., Hu, H.-P., King, C.-C., & Wang, W.-K. (2008). Antibodies to Envelope Glycoprotein of Dengue Virus during the Natural Course of Infection Are Predominantly Cross-Reactive and Recognize Epitopes Containing Highly Conserved Residues at the Fusion Loop of Domain II. Journal of Virology, 82(13), 6631–6643. https://doi.org/10.1128/JVI.00316-08. Beltramello, M., Williams, K. L., Simmons, C. P., Macagno, A., Simonelli, L., Quyen, N. T. H., & Sallusto, F. (2010). The Human Immune Response to Dengue Virus Is Dominated by Highly Cross-Reactive Antibodies Endowed with Neutralizing and Enhancing Activity. Cell Host & Microbe, 8(3), 271–283. https://doi.org/10.1016/j.chom.2010.08.007. Dejnirattisai, W., Wongwiwat, W., Supasa, S., Zhang, X., Dai, X., Rouvinski, A., & Screaton, G. R. (2015). A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nature Immunology, 16(2), 170–177. https://doi.org/10.1038/ni.3058. de Alwis, R., Smith, S. A., Olivarez, N. P., Messer, W. B., Huynh, J. P., Wahala, W. M. P. B., & de Silva, A. M. (2012). Identification of human neutralizing antibodies that bind to complex epitopes on dengue virions. Proceedings of the National Academy of Sciences, 109(19), 7439–7444. https://doi.org/10.1073/pnas.1200566109. Wahala, W. M. P. B., Kraus, A. A., Haymore, L. B., Accavitti-Loper, M. A., & de Silva, A. M. (2009). Dengue virus neutralization by human immune sera: Role of envelope protein domain III-reactive antibody. Virology, 392(1), 103–113. https://doi.org/10.1016/j.virol.2009.06.037. Williams, K. L., Wahala, W. M. P. B., Orozco, S., de Silva, A. M., & Harris, E. (2012). Antibodies targeting dengue virus envelope domain III are not required for serotype-specific protection or prevention of enhancement in vivo. Virology, 429(1), 12–20. https://doi.org/10.1016/j.virol.2012.03.003. Sukupolvi-Petty, S., Austin, S. K., Engle, M., Brien, J. D., Dowd, K. A., Williams, K. L., & Diamond, M. S. (2010). Structure and Function Analysis of Therapeutic Monoclonal Antibodies against Dengue Virus Type 2. Journal of Virology, 84(18), 9227–9239. https://doi.org/10.1128/JVI.01087-10. Sukupolvi-Petty, S., Austin, S. K., Purtha, W. E., Oliphant, T., Nybakken, G. E., Schlesinger, J. J., & Diamond, M. S. (2007). Type- and Subcomplex-Specific Neutralizing Antibodies against Domain III of Dengue Virus Type 2 Envelope Protein Recognize Adjacent Epitopes. Journal of Virology, 81(23), 12816–12826. https://doi.org/10.1128/JVI.00432-07. Sabin, A. B., & Schlesinger, R. W. (1945). Production of Immunity to Dengue with Virus Modified by Propagation in Mice. Science, 101(2634), 640–642. https://doi.org/10.1126/science.101.2634.640. Hadinegoro, S. R., Arredondo-García, J. L., Capeding, M. R., Deseda, C., Chotpitayasunondh, T., Dietze, R., & Saville, M. (2015). Efficacy and Long-Term Safety of a Dengue Vaccine in Regions of Endemic Disease. New England Journal of Medicine, 373(13), 1195–1206. https://doi.org/10.1056/NEJMoa1506223. Kirkpatrick, B. D., Durbin, A. P., Pierce, K. K., Carmolli, M. P., Tibery, C. M., Grier, P. L., & Whitehead, S. S. (2015). Robust and Balanced Immune Responses to All 4 Dengue Virus Serotypes Following Administration of a Single Dose of a Live Attenuated Tetravalent Dengue Vaccine to Healthy, Flavivirus-Naive Adults. Journal of Infectious Diseases, 212(5), 702–710. https://doi.org/10.1093/infdis/jiv082. Dejnirattisai, W., Jumnainsong, A., Onsirisakul, N., Fitton, P., Vasanawathana, S., Limpitikul, W., & Screaton, G. (2010). Cross-Reacting Antibodies Enhance Dengue Virus Infection in Humans. Science, 328(5979), 745–748. https://doi.org/10.1126/science.1185181. Thullier, P., Lafaye, P., Mégret, F., Deubel, V., Jouan, A., & Mazié, J. C. (1999). A recombinant Fab neutralizes dengue virus in vitro. Journal of Biotechnology, 69(2–3), 183–190. https://doi.org/10.1016/S0168-1656(99)00037-1. Thullier, P., Demangel, C., Bedouelle, H., Mégret, F., Jouan, A., Deubel, V., & Lafaye, P. (2001). Mapping of a dengue virus neutralizing epitope critical for the infectivity of all serotypes: insight into the neutralization mechanism. Journal of General Virology, 82(8), 1885–1892. https://doi.org/10.1099/0022-1317-82-8-1885. Cockburn, J. J. B., Navarro Sanchez, M. E., Fretes, N., Urvoas, A., Staropoli, I., Kikuti, C. M., & Rey, F. A. (2012). Mechanism of Dengue Virus Broad Cross-Neutralization by a Monoclonal Antibody. Structure, 20(2), 303–314. https://doi.org/10.1016/j.str.2012.01.001. Gromowski, G. D., Roehrig, J. T., Diamond, M. S., Lee, J. C., Pitcher, T. J., & Barrett, A. D. T. (2010). Mutations of an antibody binding energy hot spot on domain III of the dengue 2 envelope glycoprotein exploited for neutralization escape. Virology, 407(2), 237–246. https://doi.org/10.1016/j.virol.2010.06.044. Matsui, K., Gromowski, G. D., Li, L., & Barrett, A. D. T. (2010). Characterization of a dengue type-specific epitope on dengue 3 virus envelope protein domain III. Journal of General Virology, 91(9), 2249–2253. https://doi.org/10.1099/vir.0.021220-0. Shrestha, B., Brien, J. D., Sukupolvi-Petty, S., Austin, S. K., Edeling, M. A., Kim, T., & Diamond, M. S. (2010). The Development of Therapeutic Antibodies That Neutralize Homologous and Heterologous Genotypes of Dengue Virus Type 1. PLoS Pathogens, 6(4), e1000823 https://doi.org/10.1371/journal.ppat.1000823. Rey, F. A., Heinz, F. X., Mandl, C., Kunz, C., & Harrison, S. C. (1995). The envelope glycoprotein from tick-borne encephalitis virus at 2 Å resolution. Nature, 375(6529), 291–298. https://doi.org/10.1038/375291a0. Pettersen, E. F., Goddard, T. D., Huang, C. C., Couch, G. S., Greenblatt, D. M., Meng, E. C., & Ferrin, T. E. (2004). UCSF Chimera?A visualization system for exploratory research and analysis. Journal of Computational Chemistry, 25(13), 1605–1612. https://doi.org/10.1002/jcc.20084. Case, D. A., Ben-Shalom, I. Y., Brozell, S. R., Cerutti, D. S., Cheatham, III, T. E., Cruzeiro, V. W. D., … Kollman, P. A. (2018). AMBER 2018. University of California, San Francisco. Price, D. J., & Brooks, C. L. (2004). A modified TIP3P water potential for simulation with Ewald summation. The Journal of Chemical Physics, 121(20), 10096–10103. https://doi.org/10.1063/1.1808117. Maier, J. A., Martinez, C., Kasavajhala, K., Wickstrom, L., Hauser, K. E., & Simmerling, C. (2015). ff14SB: Improving the Accuracy of Protein Side Chain and Backbone Parameters from ff99SB. Journal of Chemical Theory and Computation, 11(8), 3696–3713. https://doi.org/10.1021/acs.jctc.5b00255. Kräutler, V., Gunsteren, W. Fvan, & Hünenberger, P. H. (2001). A fast SHAKE algorithm to solve distance constraint equations for small molecules in molecular dynamics simulations. Journal of Computational Chemistry, 22(5), 501–508. https://doi.org/10.1002/1096-987X(20010415)22:5<501::AID-JCC1021>3.0.CO;2-V Darden, T., York, D., & Pedersen, L. (1993). Particle mesh Ewald: An N ⋅log(N) method for Ewald sums in large systems. The Journal of Chemical Physics, 98(12), 10089–10092. https://doi.org/10.1063/1.464397. Loncharich, R. J., Brooks, B. R., & Pastor, R. W. (1992). Langevin dynamics of peptides: The frictional dependence of isomerization rates ofN-acetylalanyl-N?-methylamide. Biopolymers, 32(5), 523–535. https://doi.org/10.1002/bip.360320508. Pastor, R. W., Brooks, B. R., & Szabo, A. (1988). An analysis of the accuracy of Langevin and molecular dynamics algorithms. Molecular Physics, 65(6), 1409–1419. https://doi.org/10.1080/00268978800101881. Berendsen, H. J. C., Postma, J. P. M., van Gunsteren, W. F., DiNola, A., & Haak, J. R. (1984). Molecular dynamics with coupling to an external bath. The Journal of Chemical Physics, 81(8), 3684–3690. https://doi.org/10.1063/1.448118. Roe, D. R., & Cheatham, T. E. (2013). PTRAJ and CPPTRAJ: Software for Processing and Analysis of Molecular Dynamics Trajectory Data. Journal of Chemical Theory and Computation, 9(7), 3084–3095. https://doi.org/10.1021/ct400341p. Dannenberg, J. J. (1998). An Introduction to Hydrogen Bonding By George A. Jeffrey (University of Pittsburgh). Oxford University Press: New York and Oxford. 1997. ix + 303 pp. $60.00. ISBN 0-19-509549-9. Journal of the American Chemical Society, 120(22), 5604–5604. https://doi.org/10.1021/ja9756331. Kollman, P. A., Massova, I., Reyes, C., Kuhn, B., Huo, S., Chong, L., & Cheatham, T. E. (2000). Calculating Structures and Free Energies of Complex Molecules: Combining Molecular Mechanics and Continuum Models. Accounts of Chemical Research, 33(12), 889–897. https://doi.org/10.1021/ar000033j. Miller, B. R., McGee, T. D., Swails, J. M., Homeyer, N., Gohlke, H., & Roitberg, A. E. (2012). MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. Journal of Chemical Theory and Computation, 8(9), 3314–3321. https://doi.org/10.1021/ct300418h. Hou, T., Wang, J., Li, Y., & Wang, W. (2011). Assessing the Performance of the MM/PBSA and MM/GBSA Methods. 1. The Accuracy of Binding Free Energy Calculations Based on Molecular Dynamics Simulations. Journal of Chemical Information and Modeling, 51(1), 69–82. https://doi.org/10.1021/ci100275a. Jonniya, N. A., Sk, M. F., & Kar, P. (2020). A comparative study of structural and conformational properties of WNK kinase isoforms bound to an inhibitor: insights from molecular dynamic simulations. Journal of Biomolecular Structure and Dynamics, 0(0), 1–16. https://doi.org/10.1080/07391102.2020.1827035. Kar, P., Lipowsky, R., & Knecht, V. (2013). Importance of Polar Solvation and Configurational Entropy for Design of Antiretroviral Drugs Targeting HIV-1 Protease. The Journal of Physical Chemistry B, 117(19), 5793–5805. https://doi.org/10.1021/jp3085292. Amarnath Jonniya, N., Fulbabu Sk, M., & Kar, P. (2021). Characterizing an allosteric inhibitor-induced inactive state in with-no-lysine kinase 1 using Gaussian accelerated molecular dynamics simulations. Physical Chemistry Chemical Physics, 23(12), 7343–7358. https://doi.org/10.1039/D0CP05733A. Jonniya, N. A., Sk, M. F., & Kar, P. (2021). Elucidating specificity of an allosteric inhibitor WNK476 among With-No-Lysine kinase isoforms using molecular dynamic simulations. Chemical Biology & Drug Design, 98(3), 405–420. https://doi.org/10.1111/cbdd.13863. Jonniya, N. A., Sk, M. F., & Kar, P. (2019). Investigating Phosphorylation-Induced Conformational Changes in WNK1 Kinase by Molecular Dynamics Simulations. ACS Omega, 4(17), 17404–17416. https://doi.org/10.1021/acsomega.9b02187. Jonniya, N. A., & Kar, P. (2022). Functional Loop Dynamics and Characterization of the Inactive State of the NS2B-NS3 Dengue Protease due to Allosteric Inhibitor Binding. Journal of Chemical Information and Modeling, 62(16), 3800–3813. https://doi.org/10.1021/acs.jcim.2c00461. Roy, R., Jonniya, N. A., Poddar, S., Sk, M. F., & Kar, P. (2021). Unraveling the Molecular Mechanism of Recognition of Human Interferon-Stimulated Gene Product 15 by Coronavirus Papain-Like Proteases: A Multiscale Simulation Study. Journal of Chemical Information and Modeling. https://doi.org/10.1021/acs.jcim.1c00918 Lee, V. S., Tue-ngeun, P., Nangola, S., Kitidee, K., Jitonnom, J., Nimmanpipug, P., & Tayapiwatana, C. (2010). Pairwise decomposition of residue interaction energies of single chain Fv with HIV-1 p17 epitope variants. Molecular Immunology, 47(5), 982–990. https://doi.org/10.1016/j.molimm.2009.11.021. Ieong, P., Amaro, R. E., & Li, W. W. (2015). Molecular Dynamics Analysis of Antibody Recognition and Escape by Human H1N1 Influenza Hemagglutinin. Biophysical Journal, 108(11), 2704–2712. https://doi.org/10.1016/j.bpj.2015.04.025. Gohlke, H., Kiel, C., & Case, D. A. (2003). Insights into Protein–Protein Binding by Binding Free Energy Calculation and Free Energy Decomposition for the Ras–Raf and Ras–RalGDS Complexes. Journal of Molecular Biology, 330(4), 891–913. https://doi.org/10.1016/S0022-2836(03)00610-7. Rodrigues, C. H., Pires, D. E. & & Ascher, D. B. (2018). DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability. Nucleic Acids Research, 46(W1), W350–W355. https://doi.org/10.1093/nar/gky300. Pires, D. E. V., Ascher, D. B. & & Blundell, T. L. (2014). DUET: a server for predicting effects of mutations on protein stability using an integrated computational approach. Nucleic Acids Research, 42(W1), W314–W319. https://doi.org/10.1093/nar/gku411. da Silveira, C. H., Pires, D. E. V., Minardi, R. C., Ribeiro, C., Veloso, C. J. M., Lopes, J. C. D., & Santoro, M. M. (2009). Protein cut-off scanning: A comparative analysis of cut-off dependent and cut-off free methods for prospecting contacts in proteins. Proteins: Structure, Function, and Bioinformatics, 74(3), 727–743. https://doi.org/10.1002/prot.22187. Pires, D. E. V., Ascher, D. B., & Blundell, T. L. (2014). mCSM: predicting the effects of mutations in proteins using graph-based signatures. Bioinformatics, 30(3), 335–342. https://doi.org/10.1093/bioinformatics/btt691.